ArticleJournal for immunotherapy of cancer2023

ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3.

Yong-Qiang Ao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.